A new study concludes that pre-exposure prophylaxis (PrEP) in the form of a pill that combines the drugs emtricitabine and tenofovir disoproxil fumarate (such as Truvada) is safe for male teens. 78 diverse HIV-negative gay and bisexual men ages 15 to 17 considered to be at high risk for HIV infection participated in the study and … Continue reading PrEP Safe for Male Teens, According to New Study